BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angulo JC, Manini C, López JI, Pueyo A, Colás B, Ropero S. The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments. Cancers (Basel) 2021;13:2071. [PMID: 33922974 DOI: 10.3390/cancers13092071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Shen Z, Mo S, Dai L, Song B, Gu W, Ding X, Zhang X. Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma. Transl Oncol 2022;25:101519. [PMID: 35998436 DOI: 10.1016/j.tranon.2022.101519] [Reference Citation Analysis]
2 Xie L, Wu S, He R, Li S, Lai X, Wang Z. Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis. Front Immunol 2022;13:901662. [DOI: 10.3389/fimmu.2022.901662] [Reference Citation Analysis]
3 Manini C, López JI. Updating Clear Cell Renal Cell Carcinoma (a Tribute to Prof. Ondrej Hes). Cancers 2022;14:3990. [DOI: 10.3390/cancers14163990] [Reference Citation Analysis]
4 Ördög N, Borsos BN, Majoros H, Ujfaludi Z, Pankotai-bodó G, Bankó S, Sükösd F, Kuthi L, Pankotai T. The clinical significance of epigenetic and RNAPII variabilities occurring in clear cell renal cell carcinoma as a potential prognostic marker. Translational Oncology 2022;20:101420. [DOI: 10.1016/j.tranon.2022.101420] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang L, Su Z, Hong F, Wang L. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma. Front Cell Dev Biol 2022;10:832803. [DOI: 10.3389/fcell.2022.832803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen Q, Fu Q, Pu L, Liu X, Liu Y. Effects of HMGA2 gene silencing on cell cycle and apoptosis in the metastatic renal carcinoma cell line ACHN. J Int Med Res 2022;50:3000605221075511. [PMID: 35118889 DOI: 10.1177/03000605221075511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zou X, Guo B, Ling Q, Mo Z. Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation. Front Mol Biosci 2022;9:832238. [DOI: 10.3389/fmolb.2022.832238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Huang H, Zhu L, Huang C, Dong Y, Fan L, Tao L, Peng Z, Xiang R. Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis. Front Oncol 2021;11:726655. [PMID: 34660292 DOI: 10.3389/fonc.2021.726655] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 You Y, Ren Y, Liu J, Qu J. Promising Epigenetic Biomarkers Associated With Cancer-Associated-Fibroblasts for Progression of Kidney Renal Clear Cell Carcinoma. Front Genet 2021;12:736156. [PMID: 34630525 DOI: 10.3389/fgene.2021.736156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Laruelle A, Manini C, Iñarra E, López JI. Metastasis, an Example of Evolvability. Cancers (Basel) 2021;13:3653. [PMID: 34359555 DOI: 10.3390/cancers13153653] [Cited by in F6Publishing: 4] [Reference Citation Analysis]